Emicap SRL
Emicap reported total assets of 941,206 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Dec 2025).
The score of Emicap shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Emicap's annual accounts
| 2025 | |
|---|---|
| Net result | −205,446 € |
| Equity | 61,819 € |
| Cash | 3,001 € |
| EBITDA | −155,020 € |
| Total assets | 941,206 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 23 Dec 2025
Emicap's financial analysis
- Solvency6.6%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Emicap
Emicap's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.135.038
- VAT number
- BE0805135038
- Peppol
- Registered · 0208:0805135038 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Aug 2023
- Registered office
- 8500 Kortrijk
- Latest accounts
- 2025 · filed on 23 Dec 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Emicap (SRL) has been based in Kortrijk since 2023, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 205,446 € and equity of 61,819 €; its revenue is not published. Its solvency stands at 6.6%, below the median of its sector (61.7%).
Companies similar to Emicap
Companies in the same business, of comparable size and area, outside its group.
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Convert Pharmaceuticals Research and experimental development on natural sciences and engineering Liège · balance sheet 941,204 €
- Gynaia Belgium Research and experimental development on natural sciences and engineering Leuven · balance sheet €1.00m
- Afems Research and experimental development on natural sciences and engineering Auderghem · balance sheet 863,868 €
- Tavira Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet 863,682 €
- Jacques Coenen Group Research and experimental development on natural sciences and engineering Overijse · balance sheet €1.26m
- Digital Dental Design Robotics Research and experimental development on natural sciences and engineering Waterloo · balance sheet 676,178 €
- A-membranes Research and experimental development on natural sciences and engineering Leuven · balance sheet 633,856 €
Frequently asked questions about Emicap
What is the revenue of Emicap?
Emicap files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Emicap?
In Belgium, the VAT number is the company number prefixed with BE: BE0805135038 for Emicap, if the company is VAT-registered. Its company number (CBE) is 0805.135.038.
Where is the registered office of Emicap?
According to the CBE register, the registered office of Emicap is in 8500 Kortrijk.
What is the equity of Emicap?
At the close of the 2025 financial year, the equity of Emicap amounts to 61,819 €, a solvency of 6.6% of total assets.
Who manages Emicap?
The register lists 2 active mandates at Emicap. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Emicap
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →